The Lincoln Journal Star reports Nebraska has OK’d a second round of discussion for legislation which would allow terminal patients to try treatments not yet cleared by the U.S. Food and Drug Administration.
According to the report, Omaha Sen. Robert Hilkemann introduced the bill (LB117) with aims to offer some hope to patients.
“‘Right to try’ (legislation) removes the needless bureaucracy so that those facing the unimaginable suffering can have timely access to medication that could potentially alter their fate,” Hilkemann said.
Per the bill, patients must give written, informed consent to their doctors to test the treatments which have at least passed the first phase of safety tests.
Patients, according to the report, would be responsible for related expenses. Insurance companies would be under no obligation to pay for the treatment.